The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
about
Polyethylene Naphthalate Scintillator: A Novel Detector for the Dosimetry of Radioactive Ophthalmic ApplicatorsUveal melanoma: epidemiology, etiology, and treatment of primary disease.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineINTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures.Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rateInhibiting the effect of (90)Sr-(90)Y ophthalmic applicators on rat corneal neovascularization induced by sutures.Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransportersRecent advances and challenges in the management of retinoblastoma.A pilot study on geometrical uncertainties for intra ocular cancers in radiotherapy.Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.Brachytherapy and anterior segment imaging in iris melanoma.Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric PlacementVisual acuity, oncologic, and toxicity outcomes with 103Pd vs. 125I plaque treatment for choroidal melanoma.(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomasBrachytherapy of Uveal Melanomas with Ruthenium-106 PlaquesIndependent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.Point/Counterpoint. Particle therapy is ideal for the treatment of ocular melanomas.Choroidal melanoma: A short review with an Indian perspective.Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.Choroidal melanoma suspect. Conservative treatment and evolution. Case report.Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.Ruthenium brachytherapy for uveal melanoma - single institution experience.Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous 106Ru Eye Plaques.Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.Scleral Thinning Documented by Ultrasound Biomicroscopy after Plaque Therapy for Anterior Ciliary Melanoma.Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses.Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions.Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan.Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye PlaquesRadiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part IRadiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part IIA practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using I COMS plaques
P2860
Q28834090-70EBBD8E-9726-4BAC-BEA5-6A4D529E9F78Q30235934-8E1B4823-09A5-44C7-827D-D5F48604794EQ30388575-B6B513CE-25F0-489E-AD98-DBCD351EA8DCQ33903591-6E29E79E-26D2-4A0E-A280-EFE6ACBA76A0Q36690535-FA537A3B-F864-474C-9722-02B95334BB51Q37266865-1FED95D1-10CC-40CA-ABEB-0A47B0AF5330Q37588107-11C96FFE-4A1D-4641-856D-5BA5FC793223Q37738278-E7A5DA59-9E0A-485A-8F53-2DCED8D0F6ABQ38807602-BBF2F46F-8420-4BA1-882B-A25E642FDD72Q40054365-5C78A28B-7E51-466D-960A-54B7660853F4Q40176784-3F940794-77F5-4FBA-8579-564A9D546ACAQ41054702-D0EA8564-8CD6-44EF-9000-06C7CF476590Q41444688-D77512D7-9030-4529-B7F2-9EF17D735BBEQ41625689-17422C7B-171A-4D68-A177-26C86E5407A3Q42037875-019B46D2-9ABA-4957-BBEA-58ED044AB4B0Q42131278-3813EB51-334B-4457-8076-635FD5307D86Q42465010-14B61C6B-E8D3-4CA1-BB5B-EF8973FBF34AQ44112923-CFFAEF2A-10A0-4EB4-8264-BDBEB221B6EEQ45329352-DAB44BC5-20DC-4104-8D89-40965DA8821CQ46505542-F3F67E37-ADC9-44D0-B24B-2D0868ADC2CCQ46809059-1BAA0166-9AF9-45C3-BA9B-B35DD829AFE1Q47137241-977EDC0B-23B6-4277-9838-6CAAFB1B8322Q47724293-B9D04C39-C1F8-42CF-AED0-9A29BF3B3685Q48268832-08322BEA-0284-422B-935B-512F1518284DQ50022946-2D9F3527-2885-4F7E-8278-A0ACF32786EEQ50085739-58B10360-0C36-4903-91AD-3FAB25F5B211Q51336675-A2BFFF16-4A5F-448B-8F66-B744FD49A2B1Q52837226-6D0FBD8B-4C1B-4796-A365-342CD01687A7Q55221185-2B06118C-30AD-4F11-B5D0-5963617A299BQ55333355-E0E258A8-AD1C-4477-ABEB-A5AB92FD58DCQ55491748-51E91325-5E6C-4422-9C1A-A9F897434794Q57494862-BFF27612-E2D4-4CCA-9584-9CC5DED89452Q58779687-360EDBAD-7E33-44A5-A854-E46FE163D25AQ58779720-17F82F26-A5FD-4D2C-9EA1-EA278B804C1CQ59127189-EAA4F66A-C886-4DA3-AE92-7D8780E300CB
P2860
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The American Brachytherapy Soc ...... l melanoma and retinoblastoma.
@en
type
label
The American Brachytherapy Soc ...... l melanoma and retinoblastoma.
@en
prefLabel
The American Brachytherapy Soc ...... l melanoma and retinoblastoma.
@en
P1433
P1476
The American Brachytherapy Soc ...... l melanoma and retinoblastoma.
@en
P2093
ABS – OOTF Committee
American Brachytherapy Society ...... ress: paulfinger@eyecancer.com
P356
10.1016/J.BRACHY.2013.11.008
P577
2013-12-24T00:00:00Z